Review
Copyright ©2014 Baishideng Publishing Group Co.
World J Dermatol. May 2, 2014; 3(2): 28-35
Published online May 2, 2014. doi: 10.5314/wjd.v3.i2.28
Table 1 Psoriasis susceptibility loci identified using genome-wide association studies
PsoriasisChromosomeGeneLocusRef.
11p31.3IL-23RNair et al[11]
11p31.3IL-23RLiu et al[48]
11p31.3IL-23Rrs9988642Tsoi et al[8]
21p36RUNX3rs7536201Tsoi et al[8]
31p36.11IL28RArs7552167Tsoi et al[8]
41p36.23SLC45A1, TNFRSF9rs11121129Tsoi et al[8]
51q21PSORS4Julià et al[49]
61q21LCE3Drs6701216Liu et al[48]
71q21.3LCE3Brs4112788de Cid et al[1]
820q12-q13.12NCOA5rs2903908Zervou et al[50]
920q12-q13.2CD40rs4810485Zervou et al[50]
1020q13.13RNF114rs1056198Tsoi et al[8]
1122q11.21UBE2L3rs4821124Tsoi et al[8]
122p15B3GNT2rs10865331Tsoi et al[8]
132p16.1FLJ16341, RELrs62149416Tsoi et al[8]
142q14.2IL1RNJulià et al[49]
152q24.2KCNH7, IFIH1rs17716942Tsoi et al[8]
163p12.1CADM2Hiruma et al[51]
174q27Liu et al[48]
185q15ERAP1rs27432Tsoi et al[8]
195q31IL-13, IL-4rs1295685Tsoi et al[8]
205q31.1-q33.1IL-12Brs12188300Tsoi et al[8]
215q32-q33.1TNIP1rs17728338Bowes et al[52]
226p21.3HLA-CKnight et al[53]
236p25.3EXOC2, IRF4rs9504361Tsoi et al[8]
246q21TRAF3IP2rs33980500Ellinghaus et al[10]
256q23TNFAIP3rs582757Tsoi et al[8]
266q25.3TAGAPrs2451258Tsoi et al[8]
277p14.1ELMO1rs2700987Tsoi et al[8]
289p12DDX58rs11795343Tsoi et al[8]
299q31KLF4rs10979182Tsoi et al[8]
309q34TSC1rs1076160Bowes et al[52]
3110q22.3ZMIZ1rs1250546Tsoi et al[8]
3211q11-q13RPS6KA4, PRDX5rs645078Tsoi et al[8]
3311q22.3ZC3H12Crs4561177Tsoi et al[8]
3411q23.3ETS1rs3802826Tsoi et al[8]
3512q13.3STAT2, IL23Ars2066819Tsoi et al[8]
3613q12LHFPLiu et al[48]
3713q14.11COG6rs7993214Liu et al[48]
3814q13NFKBIArs8016947Tsoi et al[8]
3915q21rs3803369Liu et al[48]
4016p11.2PRSS53, FBXL19rs12445568Tsoi et al[8]
4116p13.13PRM3, SOCS1rs367569Tsoi et al[8]
4217q11.2-q12NOS2rs28998802Tsoi et al[8]
4317q21.31PTRF, STAT3, STAT5A/Brs963986Tsoi et al[8]
4417q25CARD14rs11652075Tsoi et al[8]
4518q21.2POL1, STARD6, MBD2rs545979Tsoi et al[8]
4618q22.1SERPINB8Julià et al[49]
4719p13.2TYK2rs34536443Tsoi et al[8]
4819p13.2ILF3, CARM1rs892085Tsoi et al[8]
Table 2 Transcriptional profiling studies targeting psoriasis in the GEO database
MicroarraysPlatformSamplesRef.
Comparison studies
GSE3424814 + 14HG-U133_Plus_2Lesional + NonLes[21]
GSE4166224 + 24HG-U133_Plus_2Lesional + NonLes[21]
GSE4166315 + 15 (+ 51 treated)HG-U133_Plus_2Lesional + NonLes[21]
GSE3099985 + 85HG-U133_Plus_2Lesional + NonLes[19]
GSE1190315 + 15 (+ 59 treated)HG-U133A_2Lesional + NonLes[18]
GSE671013 + 13HG-U133ALesional + NonLes[24]
GSE1490521 + 33 + 30HG-U133_Plus_2Healthy + Les + NonLes[16]
GSE1335564 + 58 + 58HG-U133_Plus_2Healthy + Les + NonLes[12]
GSE3240720 + 20 (+ 20 IFNg treated)HG-U133A_2Healthy + NonLes[17]
Related studies
GSE42305Monocytes[54]
GSE41905Kcytes transfected wt Antimir31[55]
GSE31652All lesional, treated placebo[56]
GSE26952Nonlesional only Psor AD[57]
GSE18948PBMCs[58]
GSE11307PCR study1
GSE6601Psor vs AD[59]
GSE417453 + 3RNA Sequencing[60]
GSE2686611 + 11 (different regions)HG-U133A_2Single vs double amplification[61]
GSE307682 +4 (+ 8 flare and relapse)HG-U133A_2Small number of samples[62]
GSE27373 + 4 + 4HG_U95Av2Small array[63]